Amoxycillin/clavulanic acid ('Augmentin') compared with a combination of aminopenicillin, aminoglycoside and metronidazole in the treatment of pelvic inflammatory disease

A randomized, multi-centre trial was carried out in 152 hospitalized women with pelvic inflammatory disease to evaluate the efficacy and tolerability of amoxycillin/clavulanic acid compared with that of a standard regimen using three antimicrobial agents (aminopenicillin, an aminoglycoside and metro...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC). - 1995. - 5(1989), 5 vom: 26., Seite 312-9
1. Verfasser: Cirau-Vigneron, N (VerfasserIn)
Weitere Verfasser: Barrier, J, Becue, J, Chartier, M, Giraud, J R, Landes, P, Leng, J, Raudrant, D, Reme, J M
Format: Aufsatz
Sprache:English
Veröffentlicht: 1989
Zugriff auf das übergeordnete Werk:Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC)
Schlagworte:Clinical Trial Comparative Study Journal Article Randomized Controlled Trial Aminoglycosides Anti-Bacterial Agents Clavulanic Acids Penicillins Metronidazole 140QMO216E mehr... Amoxicillin-Potassium Clavulanate Combination 74469-00-4 Amoxicillin 804826J2HU